tiprankstipranks
Blurbs

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Mettler-Toledo (MTD) and Irhythm Technologies (IRTC)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Mettler-Toledo (MTDResearch Report) and Irhythm Technologies (IRTCResearch Report).

Mettler-Toledo (MTD)

J.P. Morgan analyst Rachel Vatnsdal maintained a Sell rating on Mettler-Toledo on July 29 and set a price target of $1250.00. The company’s shares closed last Friday at $1349.73.

According to TipRanks.com, Vatnsdal is a 4-star analyst with an average return of 23.1% and a 61.5% success rate. Vatnsdal covers the Healthcare sector, focusing on stocks such as Quest Diagnostics, Twist Bioscience, and DENTSPLY SIRONA.

Currently, the analyst consensus on Mettler-Toledo is a Moderate Sell with an average price target of $1314.20, representing a 0.1% upside. In a report issued on July 14, Goldman Sachs also maintained a Sell rating on the stock with a $1140.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Irhythm Technologies (IRTC)

J.P. Morgan analyst Allen Gong maintained a Buy rating on Irhythm Technologies today and set a price target of $185.00. The company’s shares closed last Friday at $154.63, close to its 52-week high of $169.54.

According to TipRanks.com, Gong is a 3-star analyst with an average return of 13.4% and a 66.7% success rate. Gong covers the Healthcare sector, focusing on stocks such as TransMedics Group, Beauty Health, and NuVasive.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Irhythm Technologies with a $162.29 average price target, representing a 2.9% upside. In a report issued on July 18, BTIG also reiterated a Buy rating on the stock with a $155.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on MTD:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More